
|Articles|December 15, 2022
How purpose-built tech can help pharmaceutical and life science companies streamline healthcare provider interactions
Author(s)PwC
In today’s hypercompetitive pharmaceutical and life sciences (PLS) industry, strategic partnerships are more critical than ever. While these third-party relationships can be full of risk and regulatory challenges, the right tech can help you navigate the complexities of compliance.
Trending on PharmExec
1
Novartis to Layoff 322 NJ Employees: Report
2
Launch is Just the Beginning: Rare Disease Care Requires Durability
3
“AI as Reinvention”: Transforming the Business of Medicine
4
Pharma M&A Roundup: Chemomab Therapeutics Enters Merger Agreement with Scipher Medicine, Teva and Polpharma Biologics Enter Global Licensing Agreement
5